Magnesium and hypertension

Current Opinion in Nephrology and Hypertension

Volumn 15, Issue 2, 2006, Pages 141-144

  Touyz, Rhian M ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Blood pressure; Cations; Hypomagnesemia; Ion channels; Kidney; Vasoactive agents; Vessels

Indexed keywords

CALCIUM ION; DNA; MAGNESIUM ION; POTASSIUM ION; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SODIUM ION; TRANSIENT RECEPTOR POTENTIAL CHANNEL;

BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; EDITORIAL; ENZYME ACTIVITY; HYPERTENSION; ION TRANSPORT; OXIDATION REDUCTION REACTION; PATHOGENESIS; PREECLAMPSIA; PRIORITY JOURNAL;

ANIMALS; CELL MEMBRANE PERMEABILITY; CLUSTERIN; HOMEOSTASIS; HUMANS; HYPERTENSION; MAGNESIUM; MAGNESIUM DEFICIENCY; RATS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TRPM CATION CHANNELS;

EID: 33646792586     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mnh.0000214773.34480.d4     Document Type: Editorial

References (19)

1. Whelton PK, Klag MJ. Magnesium and blood pressure: review of the epidemiologic and clinical trial experience. Am J Cardiol 1989; 63:26G-30G.
2. Song Y, Ridker PM, Manson JE, et al. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 2005; 28:1438-1444.
3. Wolf Fl, Torsello A, Fasanella S, Cittadini A. Cell physiology of magnesium. Mol Aspects Med 2003; 24:11-26.
4. 2+ and vascular contractility. Min Elect Metab 1991; 9:323-336.
5. Laurant P, Touyz RM, Schiffrin EL. Effect of magnesium on vascular tone and reactivity in pressurized mesenteric arteries from SHR. Can J Physiol Pharmacol 1997; 5:293-300.
6. Maier JA, Bernardini D, Rayssiguier Y, Mazur A. High concentrations of magnesium modulate vascular endothelial cell behaviour in vitro. Biochim Biophys Acta 2004; 1689:6-12.
7. Mulvany MJ, Baumbach GL, Aalkjaer C, et al. Vascular remodeling. Hypertension 1996; 28:505-506.
8. 2+ responses to vasopressin in vascular smooth muscle of spontaneously hypertensive rats. J Pharmacol Exp Ther 1998; 284:998-1005.
9. Touyz RM, Yao G. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases. J Cell Physiol 2003; 197:326-335.
10. Maier JA, Malpuech-Brugere C, Zimowska W, et al. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim Biophys Acta 2004; 1689:13-21.
11. Touyz RM, Pu Q, He G, et al. Effects of low dietary magnesium intake on development of hypertension in stroke-prone spontaneously hypertensive rats: role of reactive oxygen species. J Hypertens 2002; 20:2221-2232.
12. Flatman PW. Mechanisms of magnesium transport. Annu Rev Physiol 1991; 53:259-271.
13. Zsurka G, Gregan J, Schweyen RJ. The human mitochondrial Mrs2 protein functionally substitutes for its yeast homologue, a candidate magnesium transporter. Genomics 2001; 72:158-168.
14. 2+ resorption. Science 1999; 285:103-106.
15. 2+ homeostasis by TRPM7. Cell 2003; 114:191-200.
16. Hermosura MC, Monteilh-Zoller MK, Scharenberg AM, et al. Dissociation of the store-operated calcium current I(CRAC) and the Mg-nucleotide-regulated metal ion current MagNuM. J Physiol 2002; 539:445-458.
17. Chubanov V, Waldegger S, Mederos y Schnitzler M, et al. Disruption of TRPM6/TRPM7 complex formation by a mutation in the TRPM6 gene causes hypomagnesemia with secondary hypocalcemia. PNAS 2004; 101:2894-2899.
18. He Y, Yao G, Savoia C, Touyz RM. Transient receptor potential melastatin 7 (TRPM7) ion channels regulate magnesium homeostasis in vascular smooth muscle cells. Circ Res 2005; 96:207-215.
19. Touyz RM, He Y, Montezano AC, et al. Differential regulation of TRPM6/7 cation channels by Ang II in vascular smooth muscle cells from spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2005 [Epub ahead of print].